Profitability Ratios
| Ratio |
Value |
| GP Margin |
70.5% |
| EBIT Margin |
22.1% |
| EBITDA Margin |
31.6% |
| Operating Margin |
19.1% |
| Pretax Margin |
14.3% |
| Cont. Ops Margin |
13.2% |
| Net Margin |
13.2% |
| Bottom Line Margin |
13.2% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
2.68 |
| Quick Ratio |
2.03 |
| Solvency Ratio |
0.199 |
| Cash Ratio |
0.90 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-0.95 |
| Forward PEG |
-0.95 |
| Price/Book |
1.41 |
| Price/Sales |
2.63 |
| Price/FCF |
12.59 |
| Price/Op Cash Flow |
11.71 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.2360 |
| Debt/Equity |
0.3806 |
| Debt/Capital |
0.2757 |
| Long-Term Debt/Capital |
0.2648 |
| Financial Leverage |
1.61 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
2.60 |
| Operating Cash Flow Ratio |
0.658 |
| Operating Cash Flow/Sales |
22.5% |
| Free Cash Flow/Operating Cash Flow |
93.0% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
9.17 |
| Interest Coverage |
7.6321 |
| Short-Term Operating Cash Flow Coverage |
27.42 |
| Operating Cash Flow Coverage |
0.32 |
| Capital Expenditure Coverage |
14.33 |
| Dividend + Capital Expenditure Coverage |
14.33 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
66.88 |
| EPS |
8.817 |
| Debt/Share |
49.0389 |
| Cash/Share |
26.01 |
| Book Value/Share |
124.45 |
| Tangible BV/Share |
17.64 |
| Equity/Share |
124.45 |
| Operating Cash Flow/Share |
15.028 |
| Capital Expenditure/Share |
1.048 |
| FCF/Share |
13.980 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.923 |
| Earnings Before Tax/EBIT |
0.746 |
| Price/Fair Value |
1.41 |
| Debt/Market Cap |
0.2579 |
| Effective Tax Rate |
7.7% |
| Enterprise Value Multiple |
9.60 |
BIIB - Biogen Inc.